scholarly journals Psychotropic drug use among older people in general practice: discrepancies between opinion and practice

2010 ◽  
Vol 60 (573) ◽  
pp. e156-e162 ◽  
Author(s):  
Andrea Lasserre ◽  
Nadia Younès ◽  
Thierry Blanchon ◽  
Inge Cantegreil-Kallen ◽  
Christine Passerieux ◽  
...  
2017 ◽  
Vol 1 (suppl_1) ◽  
pp. 346-346
Author(s):  
G. Boström ◽  
J. Brännström ◽  
E. Rosendahl ◽  
P. Nordström ◽  
H. Littrand ◽  
...  

1983 ◽  
Vol 13 (3) ◽  
pp. 623-633 ◽  
Author(s):  
Paul Williams

SynopsisThere have been few previous attempts to study factors which affect the duration of treatment with psychiatric drugs in general practice. In the present study ‘duration of treatment’ was regarded as analogous to ‘survival time’, and techniques of survival analysis were applied to data from a previously published study of psychotropic drug use in general practice (Williams et al. 1982). Methods of logistic modelling were used in an attempt to construct a comprehensive and parsimonious model to describe and predict the duration of psychotropic use. Such a model was found to include the effects of previous psychotropic treatment, social problems, duration of treatment and general practitioner behaviour. The implications of the findings, vis à vis the prevention of unnecessary long-term psychotropic drug use, are discussed.


2009 ◽  
Vol 17 (12) ◽  
pp. 1059-1067 ◽  
Author(s):  
Clementine Nordon ◽  
Karin Martin-Latry ◽  
Laurence de Roquefeuil ◽  
Philippe Latry ◽  
Bernard Bégaud ◽  
...  

2013 ◽  
Vol 8 (1) ◽  
pp. 82-90 ◽  
Author(s):  
Geraldine Pierre ◽  
Roland J. Thorpe ◽  
Gniesha Y. Dinwiddie ◽  
Darrell J. Gaskin

This article sought to determine whether racial disparities exist in psychotropic drug use and expenditures in a nationally representative sample of men in the United States. Data were extracted from the 2000-2009 Medical Expenditure Panel Survey, a longitudinal survey that covers the U.S. civilian noninstitutionalized population. Full-Year Consolidated, Medical Conditions, and Prescribed Medicines data files were merged across 10 years of data. The sample of interest was limited to adult males aged 18 to 64 years, who reported their race as White, Black, Hispanic, or Asian. This study employed a pooled cross-sectional design and a two-part probit generalized linear model for analyses. Minority men reported a lower probability of psychotropic drug use (Black = −4.3%, 95% confidence interval [CI] = [−5.5, −3.0]; Hispanic = −3.8%, 95% CI = [−5.1, −2.6]; Asian = −4.5%, 95% CI = [−6.2, −2.7]) compared with White men. After controlling for demographic, socioeconomic, and health status variables, there were no statistically significant race differences in drug expenditures. Consistent with previous literature, racial and ethnic disparities in the use of psychotropic drugs present problems of access to mental health care and services.


Sign in / Sign up

Export Citation Format

Share Document